Zemaira and chronic obstructive pulmonary disease Patient Reports February 09, 2010
Zemaira Side Effects Report #5751714-2
Zemaira side effect was reported by a Health Professional from UNITED STATES on May 14, 2008. Male patient, 64 years of age, weighting 180.0 lb, was diagnosed with alpha-1 anti-trypsin deficiency and was treated with Zemaira. After drug was administered, patient experienced the following side effects: bronchitis
, chronic obstructive pulmonary disease, dyspnoea, pneumonia
. Zemaira dosage: 60 UG/KG Q1W IV, 60 MG/KG Q1W IV, 60 MG/KG Q1W IV. During the same period patient was treated with ANTIBIOTICS, SINGULAIR, CELEBREX, LISINOPRIL, ADVAIR DISKUS, FLOMAX. Patient was hospitalized. Patient recovered.Zemaira Side Effects Report #5751716-6
Zemaira side effect was reported by a Health Professional from UNITED STATES on May 14, 2008. Male patient, 64 years of age, weighting 180.0 lb, was diagnosed with alpha-1 anti-trypsin deficiency and was treated with Zemaira. After drug was administered, patient experienced the following side effects: bronchitis
, chronic obstructive pulmonary disease, condition aggravated, pneumonia
. Zemaira dosage: 60 MG/KG Q1W IV, 60 MG/KG Q1W IV. During the same period patient was treated with ANTIBIOTICS, SINGULAIR, CELEBREX, LISINOPRIL, ADVAIR DISKUS, FLOMAX, SPIRIVA. Patient was hospitalized. Patient recovered.Zemaira Side Effects Report #5781213-3
Zemaira side effect was reported by a Health Professional from UNITED STATES on May 29, 2008. Male patient, 64 years of age, weighting 180.0 lb, was diagnosed with alpha-1 anti-trypsin deficiency and was treated with Zemaira. After drug was administered, patient experienced the following side effects: bronchitis
, chronic obstructive pulmonary disease, condition aggravated, dyspnoea, pneumonia
. Zemaira dosage: unknown. During the same period patient was treated with ANTIBIOTICS, SINGULAIR, CELEBREX, LISINOPRIL, ADVAIR DISKUS, FLOMAX. Patient was hospitalized. Patient recovered.Zemaira Side Effects Report #4554468-0
Zemaira side effect was reported by a Physician from on Dec 30, 2004. Male patient, 43 years of age, was diagnosed with alpha-1 anti-trypsin deficiency and was treated with Zemaira. After drug was administered, patient experienced the following side effects: cardiac failure congestive, cardiac output decreased, cardiomegaly, chronic obstructive pulmonary disease, hangover, headache
, infusion related reaction, oedema peripheral, pitting oedema. Zemaira dosage: unknown. Patient was hospitalized. Patient recovered.Zemaira Side Effects Report #4577277-5
Zemaira side effect was reported by a Physician from on Jan 20, 2005. Male patient, 43 years of age, was diagnosed with alpha-1 anti-trypsin deficiency and was treated with Zemaira. After drug was administered, patient experienced the following side effects: cardiac failure congestive, chronic obstructive pulmonary disease, hangover, headache
, infusion related reaction, oedema peripheral, pitting oedema. Zemaira dosage: unknown. Patient was hospitalized. Patient recovered.Zemaira Side Effects Report #5837789-0
Zemaira side effect was reported by a Health Professional from UNITED STATES on July 24, 2008. Male patient, 64 years of age, weighting 180.0 lb, was diagnosed with alpha-1 anti-trypsin decreased and was treated with Zemaira. After drug was administered, patient experienced the following side effects: bronchitis
, chronic obstructive pulmonary disease, condition aggravated, pneumonia
. Zemaira dosage: 60 UG/KG Q1W IV : 60 MG/KG Q1W IV : 60 MG/KG Q1W IV. During the same period patient was treated with ANTIBIOTICS, SINGULAIR, CELEBREX, ADVAIR DISKUS, FLOMAX, SPIRIVA. Patient was hospitalized. Patient recovered.
Zemaira and chronic obstructive pulmonary disease 